Sodium selenite is a potent radioprotector of the salivary glands of the rat: Acute effects on the morphology and parenchymal function during fractioned irradiation

European Archives of Oto-Rhino-Laryngology

Volumn 262, Issue 6, 2005, Pages 459-464

  Sagowski, C ^a   Wenzel, S ^a   Jenicke, L ^a   Metternich, F U ^a   Jaehne, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Fractioned irradiation; Radioprotection; Salivary glands; Sodium selenite

Indexed keywords

RADIOPROTECTIVE AGENT; SODIUM SELENITE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DEATH; CELL PROTECTION; CELL VACUOLE; CONTROLLED STUDY; DEGRANULATION; DOSE RESPONSE; EDEMA; HISTOPATHOLOGY; MALE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PROTECTION; RAT; SALIVARY GLAND DISEASE; SALIVARY GLAND FUNCTION; SCINTIGRAPHY;

ANIMALS; DOSE FRACTIONATION; GAMMA RAYS; MALE; RADIATION-PROTECTIVE AGENTS; RATS; SALIVARY GLANDS; SODIUM SELENITE;

EID: 21344458357     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-004-0859-0     Document Type: Article

References (30)

1. Bohuslavizki KH, Brenner W, Tinnemeyer S (1997) Is quantitative salivary gland scintigraphy a mandatory examination prior to and after radioiodine therapy? Radiol Oncol 31:5-12
2. Brizel DM, Wasserman T, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russel L, Oster W, Sauer (2000) Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. Int J Radiat Oncol Biol Phys 18:3339-3345
3. Brooks JD, Metter EJ, Chan DW, Sokoll IJ, Landis P, Nelson WG, Muller D, Andres R, Carter HB (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166:2034-2038
4. Chao CKS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, Low DA (2001) A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49:4:907-916
5. Chao KS, Majhail N, Huang CJ, Simpson JR, Perez CA, Haughey B, Spector G (2001) Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumour control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 61 3:275-280
6. Diamond AM, Dale P, Muray JL, Grdina DJ (1996) The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutat Res 356:147-154
7. Dörr W, Riesenbeck D (2000) Mundhöhle. In: Dörr W, Zimmermann JS, Seegenschmiedt MH (eds) Nebenwirkungen in der Radioonkologie: Klinisches Kompendium. Urban und Vogel, Munich, pp 130-142
8. Haddad P, Karimi M (2002) A randomised, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol 64:29-32
9. Hehr T, Bamberg M, Rodemann (1999) Präklinische und klinische Relevanz der radioprotektiven Wirkung von Natriumselenit. Info Onkol 2 [Suppl 2]:25-29
10. Hu YJ, Diamond AM (2003) Role of gluthathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenite. Cancer Res 63:3347-3351
11. McDonald S, Meyerowitz C, Smudzin T, Rubin P (1994) Preliminary results of a pilot study using WR2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. Int J Radiat Biol Phys 29:747-754
12. Micke O, Bruns F, Mucke R, Schafer U, Glatzel M, DeVries AF, Schonekaes K, Kisters K, Büntzel J (2003) Selenium in the treatment of radiation-associated secondary lymphedema. Int J Radiat Oncol Biol Phys 56:40-49
13. Micke R, Büntzel J, Schönekaes KG, Micke O (2003) Selen in der Onkologie: Wirklich ein "noli nocere"? Internist 44:2:227-229
14. Nagler RM, Baum BJ (2003) Prophylactic treatment reduces the severity of xerostomia following radiation therapy for oral cavity cancer. Arch Otolaryngol Head Neck Surg 129:247-250
15. Patchen ML, MacVittie TJ, Weiss JF (1990) Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys 18:1069-1075
16. Rudat V, Asadpour B, Zeh D, Wannemacher M, Debus J, Münter M, Hoffner S, Schlegel W (2001) Prospektive Untersuchung zur Schonung der Speicheldrüsenfunktion bei Patienten mit Kopf-Halskarzinomen: Vergleich IMRT versus Amifostin. Strahlenther Onkol 177:63
17. Rudat V, Meyer J, Momm F, Bendel M, Henke M, Strnad V, Grötz K, Schulte A (2000) Protective effect of amifostine on dental health after radiotherapy of the head and neck. Int J Radiat Oncol Biol Phys 48:5:1339-1343
18. Sagowski C, Tesche S, Zywietz F, Wenzel S, Metternich FU (2004) The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas. Onkologie 27:(DOI:10.1159/000075605)
19. Sagowski C, Wenzel S, Metternich FU, Kehrl W (2003) Studies on the radioprotective potency of amifostine on salivary glands of rats during fractioned irradiation: acute and late effects. Eur Arch Otorhinolaryngol 260:42-47
20. Sagowski C, Wenzel S, Tesche S, Jenicke L, Jaehne M (2003) Investigation on the radiosialadenitis during fractioned irradiation: Sialoscintigraphical and histomorphological findings in rats. Eur Arch Otorhinolaryngol 260:513-517
21. Sagowski C, Wenzel S, Tesche S, Jenicke L, Kehrl W, Roeser K, Metternich FU (2004) Reduktion akuter radiogener Schädigungen in der Glandula parotis der Ratte unter fraktionierter Bestrahlung durch Natriumselenit. HNO 52:(DOI: 10.1007/s00106-003-0992-x)
22. Scarantino CW, Levenque F, Scott C, White RL, Rotman M, Hodson DI, Meredith R, Foote L, Brachman DG, Lee N (2001) A phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients. Final results of RTOG 97-09. Int J Radiat Biol Phys 51 [Suppl 1]:85-86:A152
23. Seifert G, Mielke A, Haubrich J, Chilla R (eds) (1984) Strahlen-Sialadenitis. In: Speicheldrüsenkrankheiten. Thieme, Stuttgart, New York, pp 140-146
24. Seifert G (1996) Strahlen-Sialadenitis. In: Doerr W, Seifert G, Uehlinger E (eds) Spezielle pathologische Anatomie. Oralpahologie I: Pathologie der Speicheldrüsen. Springer, Berlin, Heidelberg, New York, pp 196-208
25. Seikaly H, Jha N, McGaw T, Coulter L, Liu R, Oldring D (2001) Submandibular gland transfer prevents postoperative radiation induced xerostomia. Laryngoscope 111:347-352
26. Shannon IL, Starke EN, Wescott WB (1977) Effect of radiotherapy on whole salivary flow. J Dent Res 44:656-661
27. Sill R (1999) Bedeutung von Selen in Prävention und komplementärer Therapie. Pharm Ztg 144:2508-2513
28. Weiss JF, Hoover RL, Kumar KS (1987) Selenium pre-treatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721. Free Radic Res Commun 3:33-38
29. Yadav SP, Gera A, Singh I, Chanda R (2002) Serum selenium levels in patients with head and neck cancer. J Otolaryngol 31:216-219
30. Ziegler H, Stegmaier C (1996) Bevölkerungsbezogene Krebsregistrierung in Deutschland. Onkologie 19:268-277